X
skip to main content
Logo

The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

News & Notices

  • Stem cell-based test predicts leukemia patients' response to therapy to help tailor treatment

    TORONTO, Canada – Dec. 7, 2016 – Leukemia researchers at Princess Margaret Cancer Centre, with funding from Terry Fox and others, have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.

    Read More View all notices

  • Ontario Node Symposium in Toronto draws large crowd; images posted

    TFRI's Ontario Node Research Symposium held on Monday, December 5 in Toronto drew over 400 people this year from across the province and beyond to hear a variety of interesting talks on the theme of Innovating Towards Transformative Cancer Care.

    Read More View all notices

  • Children from local school pay special visit to TFRI headquarters

    TFRI's office in Vancouver, BC welcomed some special guests last month with the visit of three children from the Grade 1 class at St. John's School. The trio, along with a parent and a caregiver, were here to visit with Darrell Fox, Terry's younger brother, who shared with them books and stories about Terry.

    Read More View all notices

  • 2016 Terry Fox Run update: TFRI teams show immense support, with over $105,000 raised through team/t-shirt challenge

    TFRI-funded research teams from coast to coast showed their true colours this year, turning out by the dozens in researcher-designated purple T-shirts and forming teams to raise funds for cancer research at the 36th Terry Fox Run on Sunday Sept. 18. Early estimates show the research community's fundraising efforts resulted in over $105,000 raised.

    Read More View all notices

Featured Patient Story

Bouncing back from radiation treatment to treat brain tumour

When Valeriya Zolotorgova was 10, her mother began to notice significant changes in the young girl’s hearing and vision. Following visits to doctors, Valeriya was eventually diagnosed with a brain tumour, medulloblastoma, the most common childhood malignant brain tumour with a 30 to 40 per cent mortality rate.

Read the full story
More patient stories

Watch our videos about TFRI-funded research on glioblastoma.

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.


Back to Top